NCT01587352 2026-03-18Vorinostat in Treating Patients With Metastatic Melanoma of the EyeNational Cancer Institute (NCI)Phase 2 Active not recruiting40 enrolled
NCT02836548 2025-07-10HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced MelanomaThe Netherlands Cancer InstitutePhase 1/2 Completed33 enrolled